The future of healthcare and the pharmaceutical industry – a CEO view

2004 ◽  
Vol 1 (1) ◽  
pp. 107-109
Author(s):  
Franz B. Humer
Keyword(s):  
Pharmaceutical Industry ◽  
The Future

Formation of Strategy for Sustainable Development of Entrepreneurial Structures of Pharmaceutical Industry

2021 ◽  
pp. 36-44
Author(s):  
A. Zverev ◽  
O. Kuznetsova ◽  
M. Mishina
Keyword(s):  
Sustainable Development ◽  
Economic Development ◽  
Pharmaceutical Industry ◽  
Health System ◽  
National Economy ◽  
Dimensional Approach ◽  
Expert Opinions ◽  
The Future

The article reflects the significance and peculiarities of the functioning of the entrepreneurial structure of the pharmaceutical industry, which are closely connected with the health system and play one of the key roles in the national economy of any state, influencing the future of the nation. The authors assessed the modern problems of the development of the domestic pharmaceutical industry, studied expert opinions on sustainable development options, and on this basis proposed a set of measures to optimize the economic development of Russian commercial pharmaceutical structures within the framework of the concept of a four-dimensional approach to ensuring sustainable development.

scholarly journals A Study on SWOT Analysis of Pharmaceutical Industry: The Bangladesh Context

2013 ◽  
Vol 2 (2) ◽  
pp. 200-208
Author(s):  
Meem Rafiul Hoq ◽  
Md. Ali Ahsan ◽  
Tanim–A Tabassum
Keyword(s):  
Pharmaceutical Industry ◽  
Swot Analysis ◽  
Jel Classification ◽  
Economic Factors ◽  
Pharmaceutical Sector ◽  
Threat Analysis ◽  
Industry Sector ◽  
Classification Code ◽  
Large Size ◽  
The Future

Pharmaceutical industry is one of the most important sector in Bangladesh. It is the only industry, which has its own strong manufacturing capabilities to produce the pharmaceuticals product. In this study it is tried to find out what types of strengths, weaknesses, opportunities and threats the pharmaceuticals companies face in Bangladesh. There are about 250 pharmaceuticals firms in Bangladesh. Among them some companies are the large size and more sophisticated. Some companies are small sizes and traditional qualities. A few companies dominate the whole medicine market. So they have to face severe competition in pharmaceuticals market. SOWT (Strength, Opportunity, Weakness, and Threat) analysis of any industry sector investigates the important factors that are possibility of the industry and influencing the companies operating in that sector. The purpose of this study is to analyze the pharmaceutical sector of Bangladesh using the framework of SWOT. This paper brings to light on the SWOT analysis of pharmaceuticals industry in Bangladesh and provided some valuables suggestions to overcome the weaknesses and threats, there are some suggestions to utilize the strengths and opportunities properly. Through this study the researchers try to discuss the affect of various macro-economic factors of strength, opportunity, weakness, and threat aspect on the industry and its related problems and prospects for the future. JEL Classification Code: O25; O25

scholarly journals Trend Analysis of Cost Components in Select Pharmaceutical Companies

2019 ◽  
Vol 8 (4) ◽  
pp. 2289-2298
Keyword(s):  
Pharmaceutical Industry ◽  
Trend Analysis ◽  
Health Benefits ◽  
Annual Reports ◽  
Pharmaceutical Companies ◽  
Manufacturing Costs ◽  
Operating Profit ◽  
The Future ◽  
The Cost ◽  
Cost Components

The purpose in this paper is to identify the cost components which are vital in consideration towards manufacturing especially in pharmaceutical companies. The manufacturing costs are significant in total expenses in pharmaceutical industry. In this study, a thorough investigation on the cost components and the trend in expenses and operating profit of pharma companies are studied, giving due regard to cost components to have understanding and to find out how they may differ among various types of pharma companies. The data published in the annual reports from 2009 to 2018 of top five pharmaceutical companies based on their annual revenues has been selected for further diagnosis. The analysis reveals that manufacturing costs are different for all the five companies. The study also reveals that there is a considerable indication that the companies are conscious on the much-needed health benefits to the society in the future at an affordable cost

Drug Discovery

2018 ◽  
pp. 399-404
Author(s):  
S. Nassir Ghaemi
Keyword(s):  
Drug Discovery ◽  
Pharmaceutical Industry ◽  
Discovery Process ◽  
Drug Discovery Process ◽  
New Approach ◽  
The Past ◽  
Scientific Exploration ◽  
Clinical Indications ◽  
The Future ◽  
Clinical Diagnoses

Newer and better medications are obtained as part of the drug discovery process, which occurs mainly in the pharmaceutical industry. This process is hampered by excessive attention to marketing demands, as opposed to scientific exploration. It also is impaired by the psychiatric profession’s mistaken ideologies, whether psychoanalytic orthodoxy in the past or DSM beliefs of the present. Wrong clinical phenotypes impair finding new pharmacological mechanisms and targeting them well to the write clinical indications. Perhaps as a consequence, no treatments have been developed in the last few decades, since DSM-III, that are more effective than prior agents. Progress for the future in drug discovery will require not just better neurobiological work, but also a new approach to clinical diagnoses in psychiatry.

scholarly journals ОНТОЛОГІЇ В ФАРМАЦІЇ

2015 ◽  
Author(s):  
L. Yu. Babintseva
Keyword(s):  
Pharmaceutical Industry ◽  
Expert Systems ◽  
Information Space ◽  
Exchange Of Information ◽  
Rapid Exchange ◽  
The Future ◽  
The Creation

It’s considered ontological models for formalization of knowledge in pharmacy. There is emphasized the view that the possibility of rapid exchange of information in the pharmaceutical industry, it is necessary to create a single information space. This means not only the establishment of uniform standards for the presentation of information on pharmaceutical groups pharmacotherapeutic classifications, but also the creation of a unified and standardized system for the transfer and renewal of knowledge. It is the organization of information in the ontology helps quickly in the future to build expert systems and applications to work with data.

Alternate Practice: Clinical Research

1989 ◽  
Vol 2 (2) ◽  
pp. 100-104 ◽  
Author(s):  
S. Albert Edwards
Keyword(s):  
Pharmaceutical Industry ◽  
Clinical Research ◽  
Scientific Method ◽  
Research Process ◽  
Food Additive ◽  
Major Food ◽  
Job Opportunities ◽  
The Future ◽  
Future Growth

The article describes the role of a pharmacist practicing in the area of clinical research for a major food additive company. The article also discusses clinical research in the pharmaceutical industry and includes information on what elements of a pharmacy background are useful and relevant in clinical research, as well as what a pharmacist can expect in this area. The future growth of job opportunities is also discussed. Some information is also given on the clinical research process and the underlying scientific method.

Sign in / Sign up

Export Citation Format

Share Document